培唑帕尼|已完成

登记号
CTR20131447
相关登记号
曾用名
药物类型
化学药物
临床申请受理号
企业选择不公示
适应症
肾细胞癌辅助治疗
试验通俗题目
培唑帕尼辅助治疗对术后肾细胞癌的有效性和安全性研究
试验专业题目
随机、双盲、安慰剂对照、III期研究评价培唑帕尼辅助治疗肾切除术后的局限期肾癌患者的有效性和安全性
试验方案编号
CPZP034D2301
方案最近版本号
V06
版本日期
2016-04-25
方案是否为联合用药
企业选择不公示

申请人信息

申请人名称
联系人姓名
诺华肿瘤医学热线
联系人座机
400-8180600
联系人手机号
联系人Email
china.obumi@novartis.com
联系人邮政地址
北京市-北京市-朝阳区针织路23号楼5层
联系人邮编
100004

临床试验信息

试验分类
安全性和有效性
试验分期
III期
试验目的
评价培唑帕尼作为辅助治疗对肾切除术后局限性或局部进展性肾细胞癌患者的有效性和安全性。
随机化
随机化
盲法
双盲
试验范围
国际多中心试验
设计类型
平行分组
年龄
18岁(最小年龄)至 无岁(最大年龄)
性别
男+女
健康受试者
入选标准
  • 诊断为肾细胞癌,组织学为透明细胞或以透明细胞为主型。
  • 符合基线期无病状态的标准。
  • 器官系统功能良好
  • 非转移性疾病(M0)受试者,符合综合2010年版AJCC 病理TNM分期标准和Fuhrman核分级之一:1)pT2,G3或G4,N0;或者 2)pT3,Gany,N0;或者 3)pT4,Gany,N0:或者 4)pTany,Gany,N1
  • 过去未接受过针对RCC的辅助治疗或新辅助治疗。
排除标准
  • 局部复发RCC、双侧RCC或其它恶性肿瘤病史
  • 慢性活动性肝炎的病史,包括乙肝病毒(HBV)或丙肝病毒(HCV)携带者
  • 人类免疫缺陷病毒(HIV)感染病史
  • 具有临床意义的、可能会增加胃肠道出血风险的胃肠道异常

试验分组

试验药
名称 用法
中文通用名:培唑帕尼
用法用量:片剂;规格200mg;口服,每天一次,起始剂量每次 600mg, 用药时程,连续用药,共计8到12周;然后根据受试者的安全性和耐受性,由研究者根据方案规定决定是否增加到800mg剂量水平或者保持600mg剂量水平。治疗总时程为12个月。
对照药
名称 用法
中文通用名:安慰剂
用法用量:片剂;规格200mg;口服,每天一次,起始剂量每次 600mg, 用药时程,连续用药,共计8到12周;然后根据受试者的安全性和耐受性,由研究者根据方案规定决定是否增加到800mg剂量水平或者保持600mg剂量水平。治疗总时程为12个月。

终点指标

主要终点指标
指标 评价时间 终点指标选择
无病生存期(DFS) 当获得578个DFS事件时进行评价。 有效性指标
次要终点指标
指标 评价时间 终点指标选择
总生存期(OS) 当获得578个DFS事件时进行评价。 有效性指标
生活质量 当获得578个DFS事件时进行评价。 有效性指标+安全性指标
安全性和耐受性 当获得578个DFS事件时进行评价。 安全性指标
年DFS率(如1年、2年等) 当获得578个DFS事件时进行评价。 有效性指标
数据安全监察委员会(DMC)
为受试者购买试验伤害保险

研究者信息

姓名 学位 职称 电话 Email 邮政地址 邮编 单位名称
叶定伟 医学博士 主任医师 021-64438650 dwye@shca.org.cn 上海市-上海市-徐汇区东安路270号 200032 复旦大学附属肿瘤医院

各参加机构信息

机构名称 (主要)研究者 国家 地区 城市
复旦大学附属肿瘤医院 叶定伟 中国 上海市 上海市
中国医学科学院肿瘤医院 王金万 中国 北京 北京
上海交通大学医学院附属仁济医院 黄翼然 中国 上海 上海
天津肿瘤医院 姚欣 中国 天津 天津
北京大学第三医院 马潞林 中国 北京 北京
浙江大学医学院附属第一医院 谢立平 中国 浙江 杭州
复旦大学附属华山医院 丁强 中国 上海 上海
浙江大学医学院附属第二医院 杜传军 中国 浙江 杭州
上海瑞金医院 沈周俊 中国 上海 上海
华中科技大学同济医学院附属同济医院 叶章群 中国 湖北 武汉
复旦大学附属肿瘤医院 叶定伟 中国 上海 上海
COIBA Centro de oncología e investig-Berazategui Novartis' Investigator Argentina Buenos Aires Berazategui
Instituto Alexander Fleming-Capital Federal Novartis' Investigator Argentina Buenos Aires Capital Federal
Hospital Alemán-Ciudad de Buenos Aires Novartis' Investigator Argentina Buenos Aires Ciudad de Buenos Aires
Instituto de Investigaciones Clinicas Cipolletti-Cipolletti Novartis' Investigator Argentina Río Negro Cipolletti
CER Instituto Medico-Quilmes Novartis' Investigator Argentina Quilmes Quilmes
Instituto Oncologico de Cordoba-Cordoba Novartis' Investigator Argentina Córdova Córdoba
Instituto Médico Especializado-Ciudad de Buenos Aires Novartis' Investigator Argentina Buenos Aires Ciudad de Buenos Aires
Centro Oncologico de Rosario-Rosario Novartis' Investigator Argentina Santa Fe Rosario
CEMIC-Ciudad Autonoma de Bueno Novartis' Investigator Argentina Buenos Aires Ciudad Autonoma de Bueno
Hospital Britanico de Buenos Aires-Ciudad Autónoma de Bueno Novartis' Investigator Argentina Buenos Aires Ciudad Autonoma de Buenos Aires
Fundacion RUSCULLEDA-Córdoba Novartis' Investigator Argentina Córdova Córdoba
ISIS Clinica Especializada-Santa Fe Novartis' Investigator Argentina Santa Fe Santa Fe
Sanatorio de la Providencia-Ciudad Autonoma de Bueno Novartis' Investigator Argentina Buenos Aires Ciudad Autónoma de Buenos Aires
Investigaciones Clinicas Ciudad Autonoma de Buenos-Buenos Aires Novartis' Investigator Argentina Buenos Aires Ciudad Autónoma de Buenos Aires
Centro Medico San Roque-San Miguel de Tucuman Novartis' Investigator Argentina San Miguel de Tucumán San Miguel de Tucumán
Universitaetsklinik Innsbruck-Innsbruck Novartis' Investigator Austria Innsbruck Innsbruck
LKH Salzburg-Salzburg Novartis' Investigator Austria Salzburg Salzburg
LKH Salzburg-Salzburg Novartis' Investigator Austria Salzburg Salzburg
AKH Wien-Vienna Novartis' Investigator Austria Vienna Vienna
LKH Graz-Graz Novartis' Investigator Austria Graz Graz
KH Hietzing mit Neurolog. Zentrum Rosenhügel-Vienna Novartis' Investigator Austria Vienna Vienna
Centre Hospitalier Universitaire de Liège-Liege Novartis' Investigator Belgium Liège Liège
Clinique St Elisabeth-Namur Novartis' Investigator Belgium Namur Namur
AZ St Augustinus-Wilrijk Novartis' Investigator Belgium Wilrijk Wilrijk
UZ Brussel-Brussel Novartis' Investigator Belgium Jette Jette
Heilig Hart Ziekenhuis 3-Roeselare Novartis' Investigator Belgium Roeselare Roeselare
JESSA Ziekenhuis Campus Virga Jesse-Hasselt Novartis' Investigator Belgium Hasselt Hasselt
Hospital Erasto Gaertner-Curitiba Novartis' Investigator Brazil Paraná Curitiba
Hospital Israelita Albert Einstein-Sao Paulo Novartis' Investigator Brazil Sao Paulo Sao Paulo
Hospital das Clínicas da Universidade Federal-Belo Horizonte Novartis' Investigator Brazil Minas Gerais Belo Horizonte
Instituto Nacional do Cancer - INCA-Rio de Janeiro Novartis' Investigator Brazil Rio De Janeiro Rio de Janeiro
Hospital Sirio Libanes-Sao Paulo Novartis' Investigator Brazil Sao Paulo Sao Paulo
Universidade Estadual de Campinas (UNICAMP)-Campinas Novartis' Investigator Brazil Sao Paulo Campinas
Hospital Universitário Pedro Ernesto-UERJ-Rio de Janeiro Novartis' Investigator Brazil Rio De Janeiro Rio De Janeiro
Instituto do Cancer do Estado de Sao Paulo-Sao Paulo Novartis' Investigator Brazil Sao Paulo Sao Paulo
Fundacao PIO XII - Hospital de Cancer de Barretos-Barretos Novartis' Investigator Brazil Sao Paulo Barretos
Clinica de Oncologia Medica-Sao Paulo Novartis' Investigator Brazil Sao Paulo Sao Paulo
Hospital de Caridade de Ijui-Ijui Novartis' Investigator Brazil Rio Grande Do Sul Ijui
Hospital santa marcelina-Sao Paulo Novartis' Investigator Brazil Sao Paulo Sao Paulo
PUC-RS/Hospital Sao Lucas-Porto Alegre Novartis' Investigator Brazil Rio Grande Do Sul Porto Alegre
Cross Cancer Institute-Edmonton Novartis' Investigator Canada Alberta Edmonton
Tom Baker Cancer Centre-Calgary Novartis' Investigator Canada Alberta Calgary
London Health Sciences Centre- Lawson Health-London Novartis' Investigator Canada Ontario London
Ottawa Regional Cancer Centre-Ottawa Novartis' Investigator Canada Ontario Ottawa
Lakeridge Health-Oshawa Novartis' Investigator Canada Ontario Oshawa
Princess Margaret Hospital-Toronto Novartis' Investigator Canada Ontario Toronto
CHUQ-Hotel Dieu de Quebec-Quebec Novartis' Investigator Canada Québec Québec
The Moncton Hospital-Moncton Novartis' Investigator Canada New Brunswick Moncton
Queen Elizabeth II Health Sciences Centre 2-Halifax Novartis' Investigator Canada Nova Scotia Halifax
Juravinski Cancer Centre-Hamilton Novartis' Investigator Canada Ontario Hamilton
CHUM Hopital Notre Dame-Quebec Novartis' Investigator Canada Québec Montreal
Vancouver Prostate Centre-Vancouver Novartis' Investigator Canada British Columbia Vancouver
Sunnybrook Health Sciences Centre-Toronto Novartis' Investigator Canada Ontario Toronto
Fundación Arturo López Pérez-Santiago-Chile-C Novartis' Investigator Chile Región Metro De Santiago Santiago
Instituto Oncologico-Vina del Mar-Chile-C Novartis' Investigator Chile Valparaíso Vina del Mar
Masarykova nemocnice-Usti nad Labem-Czech Republic-C Novartis' Investigator Czech Republic Usti nad Labem Usti nad Labem
VFN Praha 2-Praha 2-Czech Republic-C Novartis' Investigator Czech Republic Praha 2 Praha 2
Nemocnice Na Bulovce-Praha 8-Czech Republic-C Novartis' Investigator Czech Republic Praha 8 Praha 8
FNsP u sv. Anny-Brno-Czech Republic-C Novartis' Investigator Czech Republic Brno Brno
FN Plzen 2-Plzen-Czech Republic-C Novartis' Investigator Czech Republic Plzen Plzen
FN Hradec Kralove 5-Hradec Kralove-Czech Republic-C Novartis' Investigator Czech Republic Hradec Kralove Hradec Kralove
FN Olomouc-Olomouc-Czech Republic-C Novartis' Investigator Czech Republic Olomouc Olomouc
FNsP Ostrava- Poruba-Ostrava - Poruba-Czech Republic-C Novartis' Investigator Czech Republic Ostrava - Poruba Ostrava - Poruba
Masarykuv onkologicky ustav-Brno-Czech Republic-C Novartis' Investigator Czech Republic Brno Brno
Nemocnice Novy Jicin-Novy Jicin-Czech Republic-C Novartis' Investigator Czech Republic Novy Jicin Novy Jicin
Herlev Hospital-Herlev-Denmark-C Novartis' Investigator Denmark Herlev Herlev
Aarhus Universitetshospital, Aarhus Sygehus-Aarhus-Denmark-C Novartis' Investigator Denmark Aarhus Aarhus
Odense Universitetshospital-Odense C-Denmark-C Novartis' Investigator Denmark Odense C Odense C
Centre Francois Baclesse-Caen cedex 5-France-C Novartis' Investigator France Caen Cedex 05 Caen Cedex 05
Institut Mutualiste Montsouris-Paris-France-C Novartis' Investigator France Paris Paris
Centre Eugène Marquis-Rennes-France-C Novartis' Investigator France Rennes Rennes
CHU de Poitiers - Hopital de la Milétrie-Poitiers cedex-France-C Novartis' Investigator France Poitiers Cedex Poitiers Cedex
HUS - Nouvel Hopital Civil-Strasbourg cedex-France-C Novartis' Investigator France Strasbourg Cedex Strasbourg Cedex
Institut de Cancérologie Paul Papin-Angers cedex 9-France-C Novartis' Investigator France Angers cedex 9 Angers cedex 9
Institut Cancérologie de l’Ouest - René Gauducheau-Saint-Herblain cedex-France-C Novartis' Investigator France Saint Herblain Saint Herblain
Hopital Européen Georges Pompidou-Paris cedex 15-France-C Novartis' Investigator France Paris Cedex 15 Paris Cedex 15
Polyclinique Courlancy-Reims-France-C Novartis' Investigator France Reims Reims
CHRU de Tours - Hopital Bretonneau-Tours cedex 9-France-C Novartis' Investigator France Tours Cedex 9 Tours Cedex 9
Clinique Sainte Marguerite-Hyeres-France-C Novartis' Investigator France Hyeres Hyeres
CHU de Montpellier - Hopital Saint-Eloi-Montpellier cedex 5-France-C Novartis' Investigator France Montpellier Cedex 5 Montpellier Cedex 5
CHU de Bordeaux - Hopital Saint André-Bordeaux-France-C Novartis' Investigator France Bordeaux Bordeaux
Centre Léon Bérard-Lyon cedex 08-France-C Novartis' Investigator France Lyon Cedex 08 Lyon Cedex 08
CHU de Marseille - Hopital de la Timone-Marseille cedex 5-France-C Novartis' Investigator France Marseille cedex 5 Marseille cedex 5
CHU de Besancon - Hopital Jean Minjoz-Besancon cedex-France-C Novartis' Investigator France Besancon cedex Besancon cedex
Centre Jean Bernard - Clinique Victor Hugo-Le Mans-France-C Novartis' Investigator France Le Mans Le Mans
Clinique Pasteur-Toulouse-France-C Novartis' Investigator France Toulouse Toulouse
Clinique Sainte Anne-Strasbourg cedex-France-C Novartis' Investigator France Strasbourg cedex Strasbourg cedex
Gem. Praxis Drs. Woerner und Rudolph-Kirchheim-Germany-C Novartis' Investigator Germany Baden-Wuerttemberg Kirchheim
Universitaetsklinikum Marburg-Urologie-Marburg-Germany-C Novartis' Investigator Germany Hessen Marburg
Praxis Dr. med. Jochen Wilke-Fuerth-Germany-C Novartis' Investigator Germany Bayern Fuerth
Helios Klinikum Erfurt-Urologie-Erfurt-Germany-C Novartis' Investigator Germany Freistaat Thüringen Erfurt
Universitaetsklinikum Bonn-Urologie-Bonn-Germany-C Novartis' Investigator Germany Nordrhein-Westfalen Bonn
Klinikum Offenbach GmbH-Urologische Klinik-Offenbach-Germany-C Novartis' Investigator Germany Hessen Offenbach
Universitaetsklinikum Muenster-Urologie-Muenster-Germany-C Novartis' Investigator Germany Nordrhein-Westfalen Muenster
Uniklinik Schleswig-Holstein-Campus Luebeck-Urolog-Luebeck-Germany-C Novartis' Investigator Germany Schleswig-Holstein Luebeck
Universitaetsklinikum des Saarlandes-Urologie-Homburg/Saar-Germany-C Novartis' Investigator Germany Saarland Homburg
Universitaetsklinikum Ulm-Urologie-Ulm-Germany-C Novartis' Investigator Germany Baden-Wuerttemberg Ulm
Praxis Dr. med. Ralf Eckert-Eisleben-Germany-C Novartis' Investigator Germany Sachsen-Anhalt Eisleben
Charite-Campus Mitte-Urologie-Berlin-Germany-C Novartis' Investigator Germany Berlin Berlin
Universitaetsklinikum Aachen-Urologie-Aachen-Germany-C Novartis' Investigator Germany Nordrhein-Westfalen Aachen
Praxis Dr. med. Goetz Geiges-Berlin-Germany-C Novartis' Investigator Germany Berlin Berlin
Katharinenhospital Stuttgart-Stuttgart-Germany-C Novartis' Investigator Germany Baden-Wuerttemberg Stuttgart
Universitaetsklinikum Jena-Urologie-Jena-Germany-C Novartis' Investigator Germany Thueringen Jena
Krankenhaus Am Urban-Berlin-Germany-C Novartis' Investigator Germany Berlin Berlin
Waldkrankenhaus St. Marien-Erlangen-Germany-C Novartis' Investigator Germany Bayern Erlangen
Praxis Dr. med. Toralf Kellner-Plauen-Germany-C Novartis' Investigator Germany Sachsen Plauen
Klinikum rechts der Isar-Urologie-Muenchen-Germany-C Novartis' Investigator Germany Bayern Muenchen
Klinikum der J. W. Goethe-Universitaet-Med. K. II-Frankfurt-Germany-C Novartis' Investigator Germany Hessen Frankfurt
Kreiskrankenhaus Sigmaringen-Urologie-Sigmaringen-Germany-C Novartis' Investigator Germany Baden-Wuerttemberg Sigmaringen
Praxis Dr. med. Hans Werner Tessen-Goslar-Germany-C Novartis' Investigator Germany Niedersachsen Goslar
Universitaetsklinikum der GHS Essen-Tumorforschung-Essen-Germany-C Novartis' Investigator Germany Nordrhein-Westfalen Essen
Martin-Luther-Universitaet Halle-Urologie-Halle-Germany-C Novartis' Investigator Germany Sachsen-Anhalt Halle
Johannes-Gutenberg-Universitaet Mainz-Urologie-Mainz-Germany-C Novartis' Investigator Germany Rheinland-Pfalz Mainz
Studienzentrum Onkologie Ravensburg im Brustzentru-Ravensburg-Germany-C Novartis' Investigator Germany Baden-Wuerttemberg Ravensburg
Staedtische Kliniken Neuss Lukaskrankenhaus-Urol.-Neuss-Germany-C Novartis' Investigator Germany Nordrhein-Westfalen Neuss
Caritas-Krankenhaus St. Josef-Urologie-Regensburg-Germany-C Novartis' Investigator Germany Bayern Regensburg
Duisburger Fachaerztegemeinschaft Urologie-Duisburg-Germany-C Novartis' Investigator Germany Nordrhein-Westfalen Duisburg
Klinikum Nordoberpfalz-Weiden-Urologie-Weiden-Germany-C Novartis' Investigator Germany Bayern Weiden
Zeisigwaldkliniken Bethanien-Urologie-Chemnitz-Germany-C Novartis' Investigator Germany Sachsen Chemnitz
Universitaetsklinikum Eppendorf-Urologie-Hamburg-Germany-C Novartis' Investigator Germany Hamburg Hamburg
Medizinische Hochschule Hannover-Urologie-Hannover-Germany-C Novartis' Investigator Germany Niedersachsen Hannover
Diakonissenkrankenhaus Dessau gGmbH-Urologie-Dessau-Germany-C Novartis' Investigator Germany Sachsen-Anhalt Dessau
Klinikum Bremen-Mitte gGmbH-Urologische Klinik-Bremen-Germany-C Novartis' Investigator Germany Bremen Bremen
Universitaetsklinikum Tuebingen-Urologie-Tuebingen-Germany-C Novartis' Investigator Germany Baden-Wuerttemberg Tuebingen
Klinikum Braunschweig-Urologische Klinik-Braunschweig-Germany-C Novartis' Investigator Germany Niedersachsen Braunschweig
Kliniken Maria Hilf-Klinik fuer Urologie-Moenchengladbach-Germany-C Novartis' Investigator Germany Nordrhein-Westfalen Moenchengladbach
Marien-Krankenhaus-Bergisch Gladbach-Germany-C Novartis' Investigator Germany Nordrhein-Westfalen Bergisch Gladbach
Gem. Praxis Drs. Nusch und Kalhori-Velbert-Germany-C Novartis' Investigator Germany Nordrhein-Westfalen Velbert
Klinikum Grosshadern-Urologie-Muenchen-Germany-C Novartis' Investigator Germany Bayern Muenchen
VITURO, Ges.f. klinische Studien, Ur-Leipzig-Germany-C Novartis' Investigator Germany Sachsen Leipzig
University Hospital of Patras-Patra-Greece-C Novartis' Investigator Greece Rio-Patras Rio-Patras
University Hospital of Heraklion-Heraklion, Crete-Greece-C Novartis' Investigator Greece Heraklion, Crete Heraklion, Crete
General Hospital of Athens Novartis' Investigator Greece Athens Athens
Agios Savvas Hospital-Athens-Greece-C Novartis' Investigator Greece Athens Athens
Euromedica General Clinic of Thessaloniki-Thessaloniki-Greece-C Novartis' Investigator Greece Thessaloniki Thessaloniki
Vas Megyei Markusovszky Lajos Kórház-Szombathely-Hungary-C Novartis' Investigator Hungary Szombathely Szombathely
Országos Onkológiai Intézet-Budapest-Hungary-C Novartis' Investigator Hungary Budapest Budapest
B-A-Z Megyei Kórház-Miskolc-Hungary-C Novartis' Investigator Hungary Miskolc Miskolc
Szabolcs-Szatmár-Bereg Megyei Onkormányzat-Nyíregyháza-Hungary-C Novartis' Investigator Hungary Nyíregyháza Nyíregyháza
Semmelweis Egyetem-Budapest-Hungary-C Novartis' Investigator Hungary Budapest Budapest
Fov Onk. Egyesített St István-St László Kórház-RI-Budapest-Hungary-C Novartis' Investigator Hungary Budapest Budapest
Beaumont Hospital-Dublin 9-Ireland-C Novartis' Investigator Ireland Dublin Dublin
Mater Misericordiae Hospital-Dublin-Ireland-C Novartis' Investigator Ireland Dublin Dublin
University Hospital Galway-Galway-Ireland-C Novartis' Investigator Ireland Galway Galway
Cork University Hospital-Cork-Ireland-C Novartis' Investigator Ireland Wilton Cork
Adelaide & Meath Hospital-Dublin-Ireland-C Novartis' Investigator Ireland Dublin Dublin
St Vincent's University Hospital - D-Dublin-Ireland-C Novartis' Investigator Ireland Dublin Dublin
Mater Private Hospital-Dublin-Ireland-C Novartis' Investigator Ireland Dublin Dublin
Rabin MC, Campus Beilinson-Petach Tikva-Israel-C Novartis' Investigator Israel Petah-Tikva Petah-Tikva
Kaplan MC-Rehovot-Israel-C Novartis' Investigator Israel Rehovot Rehovot
Rambam MC-Haifa-Israel-C Novartis' Investigator Israel Haifa Haifa
Hadassah Ein-Kerem MC.-Jerusalem-Israel-C Novartis' Investigator Israel Jerusalem Jerusalem
Assaf Harofeh MC-Zrifin-Israel-C Novartis' Investigator Israel Zrifin Zrifin
Tel-Aviv Sourasky MC-Tel Aviv-Israel-C Novartis' Investigator Israel Tel Aviv Tel Aviv
Policlinico di Modena - A.O. Universitaria-Modena-Italy-C Novartis' Investigator Italy Emilia-Romagna Modena
Fondazione IRCCS Policlinico San Matteo-Pavia-Italy-C Novartis' Investigator Italy Lombardia Pavia
Ospedale San Donato - USL 8-Arezzo-Italy-C Novartis' Investigator Italy Toscana Arezzo
Istituto Nazionale Tumori-Milano-Italy-C Novartis' Investigator Italy Lombardia Milano
Azienda Ospedaliera Santa Maria-Terni-Italy-C Novartis' Investigator Italy Umbria Terni
Ist per la Ricerca ed il Trattamento del Cancro-Candiolo (TO)-Italy-C Novartis' Investigator Italy Piemonte Candiolo
AO Rilievo Nazionale A.Cardarelli-Napoli-Italy-C Novartis' Investigator Italy Campania Napoli
AOU di Bologna Policlinico S.Orsola - Malpighi-Bologna-Italy-C Novartis' Investigator Italy Emilia-Romagna Bologna
Azienda Ospedaliera San Camillo Forlanini-Roma-Italy-C Novartis' Investigator Italy Lazio Roma
Ist. Scientifico Romagnolo Studio e Cura Tumori-Meldola (FC)-Italy-C Novartis' Investigator Italy Emilia-Romagna Meldola (FC)
Azienda Ospedaliera Sacro Cuore - Don Calabria-Negrar (Verona)-Italy-C Novartis' Investigator Italy Veneto Negrar
I.F.O. Regina Elena - San Gallicano-Roma-Italy-C Novartis' Investigator Italy Lazio Roma
Yamagata University Hospital-Yamagata-Japan-C Novartis' Investigator Japan Yamagata Yamagata
Keio University Hospital-Tokyo-Japan-C Novartis' Investigator Japan Tokyo Tokyo
Yokohama City University Hospital-Kanagawa-Japan-C Novartis' Investigator Japan Kanagawa Kanagawa
Okayama University Hospital-Okayama-Japan-C Novartis' Investigator Japan Okayama Okayama
The Cancer Institute Hospital of JFCR (Ariake)-Tokyo-Japan-C Novartis' Investigator Japan Tokyo Tokyo
Hokkaido University Hospital-Hokkaido-Japan-C Novartis' Investigator Japan Hokkaido Hokkaido
Nippon Medical School Hospital-Tokyo-Japan-C Novartis' Investigator Japan Tokyo Tokyo
Kyushu University Hospital-Fukuoka-Japan-C Novartis' Investigator Japan Fukuoka Fukuoka
Kinki University Hospital-Osaka-Japan-C Novartis' Investigator Japan Osaka Osaka
Hamamatsu University School of Medicine-Shizuoka-Japan-C Novartis' Investigator Japan Shizuoka Shizuoka
Tokyo Women's Medical University Hospital-Tokyo-Japan-C Novartis' Investigator Japan Tokyo Tokyo
Sapporo Medical University Hospital-Hokkaido-Japan-C Novartis' Investigator Japan Hokkaido Hokkaido
National Cancer Center-Gyeonggi-do-Korea-C Novartis' Investigator Korea, Republic of Gyeonggi-do Gyeonggi-do
Seoul National University Bundang Hospital-Seongnam-si, Gyeonggi-do-Korea-C Novartis' Investigator Korea, Republic of Seongnam-si Gyeonggi-do Seongnam-si Gyeonggi-do
Korea University Anam Hospital-Seoul-Korea-C Novartis' Investigator Korea, Republic of Seoul Seoul
Samsung Medical Center-Seoul-Korea-C Novartis' Investigator Korea, Republic of Seoul Seoul
Severance Hospital, YUCM-Seoul-Korea-C Novartis' Investigator Korea, Republic of Seodaemun-gu, Seoul Seodaemun-gu, Seoul
Seoul National University Hospital 1-Seoul-Korea-C Novartis' Investigator Korea, Republic of Seoul Seoul
Chonbuk National University Hospital-Chonju/Jeonju-Korea-C Novartis' Investigator Korea, Republic of Jeonju Jeonju
Chungnam National University Hospital-Daejeon-Korea-C Novartis' Investigator Korea, Republic of Daejeon Daejeon
Asan Medical Center-Seoul-Korea-C Novartis' Investigator Korea, Republic of Seoul Seoul
Centre Hospitalier de Luxembourg-Luxembourg-Luxembourg-C Novartis' Investigator Luxembourg Luxembourg Luxembourg
Wojewodzki Szpital Specjalistyczny-Wroclaw-Poland-C Novartis' Investigator Poland Wroclaw Wroclaw
NZOZ VESALIUS-Krakow-Poland-C Novartis' Investigator Poland Kraków Kraków
Centrum Onkologii Instytut im.M.Sklodowskiej-Curie-Krakow-Poland-C Novartis' Investigator Poland Krakow Krakow
Przychodnia Lekarska NZOZ Komed-Konin-Poland-C Novartis' Investigator Poland Konin Konin
Centrum Medyczne Ostrobramska NZOZ MAGODENT-Warszawa-Poland-C Novartis' Investigator Poland Warszawa Warszawa
Centrum Onkologii Ziemi Lubelskiej-Lublin-Poland-C Novartis' Investigator Poland Lublin Lublin
Szpital Kliniczny Przemienienia Panskiego-Poznan-Poland-C Novartis' Investigator Poland Poznan Poznan
NZOZ Mazowiecki Szpital Onkologiczny-Wieliszew-Poland-C Novartis' Investigator Poland Wieliszew Wieliszew
Centrum Onkologii-Instytut im.M.Sklodowskiej-Curie-Warszawa-Poland-C Novartis' Investigator Poland Warszawa Warszawa
Wojewodzkie Centrum Onkologii-Gdansk-Poland-C Novartis' Investigator Poland Gdansk Gdansk
ONKOLMED Lecznica Onkologiczna-Warszawa-Poland-C Novartis' Investigator Poland Warszawa Warszawa
Akademicki Szpital Kliniczny im. Jana Mikulicza-Wroclaw-Poland-C Novartis' Investigator Poland Wroclaw Wroclaw
Wojewodzki Szpital Specjalistyczny im.M. Kopernika-Lodz-Poland-C Novartis' Investigator Poland Lodz Lodz
Russian Scientific Center of Roentgeno-Radiology-Moscow-Russian Federation-C Novartis' Investigator Russian Federation Moscow Moscow
Russian Cancer Research Centre n.a Blokhin,RAMS-Moscow-Russian Federation-C Novartis' Investigator Russian Federation Moscow Moscow
City Hospital #2-Saint Petersburg-Russian Federation-C Novartis' Investigator Russian Federation Saint Petersburg Saint Petersburg
Petrov Research Institute of Oncology-St. Petersburg-Russian Federation-C Novartis' Investigator Russian Federation St. Petersburg St. Petersburg
Regional Clinical Oncology Dispensary-Ryazan-Russian Federation-C Novartis' Investigator Russian Federation Ryazan Ryazan
Tatarstan Republic Clinical Oncology Dispensary-Kazan-Russian Federation-C Novartis' Investigator Russian Federation Kazan Kazan
Sverdlovsk Regional Clinical Hospital-Ekaterinburg-Russian Federation-C Novartis' Investigator Russian Federation Ekaterinburg Ekaterinburg
Rostov Central Clinical Hospital-Rostov on Don-Russian Federation-C Novartis' Investigator Russian Federation Rostov-na-Donu Rostov-na-Donu
GUZ Novartis' Investigator Russian Federation Ufa Ufa
Stavropol Regional Clinical Oncological Dispensary-Stavropol-Russian Federation-C Novartis' Investigator Russian Federation Stavropol Stavropol
Regional Oncology Dispensary-Chelyabinsk-Russian Federation-C Novartis' Investigator Russian Federation Chelyabinsk Chelyabinsk
Oncology Dispensary-Omsk-Russian Federation-C Novartis' Investigator Russian Federation Omsk Omsk
Arkhangelsk Regional Oncology Dispensery-Arkhangelsk-Russian Federation-C Novartis' Investigator Russian Federation Arkhangelsk Arkhangelsk
Medical Roentgenology Resesarch Center-Obninsk-Russian Federation-C Novartis' Investigator Russian Federation Obninsk Obninsk
Altai Regional Oncology Dispensary-Barnaul-Russian Federation-C Novartis' Investigator Russian Federation Barnaul Barnaul
Univerzitna nemocnica L.Pasteura Kosice-Kosice-Slovakia-C Novartis' Investigator Slovakia Kosice Kosice
FNsP F.D. Roosevelta-Banska Bystrica-Slovakia-C Novartis' Investigator Slovakia Banska Bystrica Banska Bystrica
Fakultna nemocnica s poliklinikou Zilina-Zilina-Slovakia-C Novartis' Investigator Slovakia Zilina Zilina
Univerzitna nemocnica Martin-Martin-Slovakia-C Novartis' Investigator Slovakia Martin Martin
Univerzitna nemocnica Bratislava-Bratislava-Slovakia-C Novartis' Investigator Slovakia Bratislava Bratislava
Instituto Valenciano Oncologico-Valencia-Spain-C Novartis' Investigator Spain Valencia Valencia
Hospital 12 De Octubre-Madrid-Spain-C Novartis' Investigator Spain Madrid Madrid
Hospital Reina Sofia 1-Cordoba-Spain-C Novartis' Investigator Spain Córdova Córdoba
Hospital Virgen del Rocío-Sevilla-Spain-C Novartis' Investigator Spain Sevilla Sevilla
Hospital Central de Asturias-Oviedo-Spain-C Novartis' Investigator Spain Oviedo Oviedo
Hospital Clinico Universitario Virgen Victoria 2-Malaga-Spain-C Novartis' Investigator Spain Málaga Málaga
Hospital Universitario Valle de Hebr-Barcelona-Spain-C Novartis' Investigator Spain Barcelona Barcelona
Hospital Gregorio Maranon-Madrid-Spain-C Novartis' Investigator Spain Madrid Madrid
Hospital Germans Trias I Pujol 2-Badalona-Spain-C Novartis' Investigator Spain Badalona Badalona
Centro Oncológico Integral Clara Campal-Madrid-Spain-C Novartis' Investigator Spain Madrid Madrid
Hospital Clinic-Barcelona-Spain-C Novartis' Investigator Spain Barcelona Barcelona
Complejo Hospitalario Nuestra Sra. de Valme-Sevilla-Spain-C Novartis' Investigator Spain Sevilla Sevilla
MD Anderson-Madrid-Spain-C Novartis' Investigator Spain Madrid Madrid
Ege University SoM-Bornova/Izmir-Turkey-C Novartis' Investigator Turkey Izmir Izmir
Cukurova University School of Medicine-Adana-Turkey-C Novartis' Investigator Turkey Adana Adana
Ankara University Medical Faculty Ce-Ankara-Turkey-C Novartis' Investigator Turkey Ankara Ankara
Hacettepe University School of Medicine-Ankara-Turkey-C Novartis' Investigator Turkey Ankara Ankara
Istanbul University Oncology Institute-Istanbul-Turkey-C Novartis' Investigator Turkey Istanbul Istanbul
Royal Free Hospital-London-United Kingdom-C Novartis' Investigator United Kingdom London London
Royal Sussex County Hospital-Brighton-United Kingdom-C Novartis' Investigator United Kingdom Brighton Brighton
Bristol Haematology and Oncology Centre-Bristol-United Kingdom-C Novartis' Investigator United Kingdom Gloucestershire Bristol
Christie Hospital NHS Foundation Trust-Manchester-United Kingdom-C Novartis' Investigator United Kingdom Manchester Manchester
Royal Cornwall Hospital-Truro-United Kingdom-C Novartis' Investigator United Kingdom Cornwall Cornwall
Royal Preston Hospital-Preston-United Kingdom-C Novartis' Investigator United Kingdom Lancashire Preston
The Royal Wolverhampton Hospitals NHS Trust-Wolverhampton-United Kingdom-C Novartis' Investigator United Kingdom Wolverhampton Wolverhampton
Royal Surrey County Hospital NHS Foundation Trust-Guidlford, Surrey-United Kingdom-C Novartis' Investigator United Kingdom Surrey Guildford
Guy's & St THomas' NHS Foundation Trust-London-United Kingdom-C Novartis' Investigator United Kingdom London London
Singleton hospital-Swansea-United Kingdom-C Novartis' Investigator United Kingdom West Glamorgan Swansea
Tennessee Oncology PLLC-Chattanooga-United States-C Novartis' Investigator United States Tennessee Chattanooga
Duke University Medical Center-Durham-United States-C Novartis' Investigator United States North Carolina Durham
Mayo Clinic Cancer Center-Rochester-United States-C Novartis' Investigator United States Minnesota Rochester
Tyler Cancer Center-Tyler-United States-C Novartis' Investigator United States Texas Tyler
Northeast Georgia Cancer Care, LLC-Athens-United States-C Novartis' Investigator United States Georgia Athens
Ohio Sate University-Columbus-United States-C Novartis' Investigator United States Ohio Columbus
Kaiser Permanente Medical Center-San Jose-United States-C Novartis' Investigator United States California San Jose
Kaiser Permanente Medical Center-San Francisco-United States-C Novartis' Investigator United States California San Francisco
H. Lee Moffitt Cancer Center & Research Institute-Tampa-United States-C Novartis' Investigator United States Florida Tampa
University of Chicago Medical Center-Chicago-United States-C Novartis' Investigator United States Illinois Chicago
University Maryland Hospital-Baltimore-United States-C Novartis' Investigator United States Maryland Baltimore
University of California and Medical Center-San Diego-United States-C Novartis' Investigator United States California La Jolla
The University of Minnesota-Minneapolis-United States-C Novartis' Investigator United States Minnesota Minneapolis
Loyola University Medical Center 1-Maywood-United States-C Novartis' Investigator United States Illinois Maywood
Medical University of South Carolina-Charleston-United States-C Novartis' Investigator United States South Carolina Charleston
Fox Chase Cancer Center-Philadelphia-United States-C Novartis' Investigator United States Pennsylvania Philadelphia
Fox Chase Cancer Center-Philadelphia-United States-C Novartis' Investigator United States Pennsylvania Philadelphia
LAC & USC Medical Center 3-Los Angeles-United States-C Novartis' Investigator United States California Los Angeles
Rosewell Park Cancer Institute-Buffalo-United States-C Novartis' Investigator United States New York Buffalo
Sammons Cancer Center-Dallas-United States-C Novartis' Investigator United States Texas Dallas
Willamette Valley Cancer Center-Eugene-United States-C Novartis' Investigator United States Oregon Springfield
Huntsman Cancer Institute- University of Utah-Salt Lake City-United States-C Novartis' Investigator United States Utah Salt Lake City
MD Anderson Cancer Center-Orlando-United States-C Novartis' Investigator United States Florida Orlando
The Emory Clinic-Atlanta-United States-C Novartis' Investigator United States Georgia Atlanta
Eastern CT Hematology Oncology Associates-Norwich-United States-C Novartis' Investigator United States Vermont Norwich
Cancer Care Centers of South Texas-San Antonio-United States-C Novartis' Investigator United States Texas San Antonio
San Francisco Oncology Associates 1-San Francisco-United States-C Novartis' Investigator United States California San Francisco
Southeast Nebraska Cancer Center-Lincoln-United States-C Novartis' Investigator United States Nebraska Lincoln
Kaiser Permanente, Oakland-Oakland-United States-C Novartis' Investigator United States California Oakland
Illinois Cancer Care-Peoria-United States-C Novartis' Investigator United States Illinois Peoria
Karmanos Cancer Institute-Detroit-United States-C Novartis' Investigator United States Michigan Detroit
Northwestern University-Chicago-United States-C Novartis' Investigator United States Illinois Chicago
Rhode Island Hospital-Providence-United States-C Novartis' Investigator United States Rhode Island Providence
The Miriam Hospital-Providence-United States-C Novartis' Investigator United States Rhode Island Providence
University of Pennsylvania-Philadelphia-United States-C Novartis' Investigator United States Pennsylvania Philadelphia
Mayo Clinic of Scottsdale-Scottsdale-United States-C Novartis' Investigator United States Arizona Scottsdale
Greater Baltimore Medical Center-Baltimore-United States-C Novartis' Investigator United States Maryland Baltimore
Dartmouth-Hitchcock Medical Center-Lebanon-United States-C Novartis' Investigator United States New Hampshire Lebanon
Northwestern Carolina Oncology and Hematology-Hickory-United States-C Novartis' Investigator United States North Carolina Hickory
Cornell (New York Presbyterian Hospital)-New York-United States-C Novartis' Investigator United States New York New York
Rush University Medical Center-Chicago-United States-C Novartis' Investigator United States Illinois Chicago
The University of Texas Health Science Center-San Antonio-United States-C Novartis' Investigator United States Texas San Antonio
North Mississippi Hematology & Oncology Assoc-Tupelo-United States-C Novartis' Investigator United States Mississippi Tupelo
Case Western Reserve University-Cleveland-United States-C Novartis' Investigator United States Ohio Cleveland
Duke University Medical Center-Durham-United States-C Novartis' Investigator United States North Carolina Durhman
Seattle Cancer Care Alliance-Seattle-United States-C Novartis' Investigator United States Washington Seattle
University of Virginia Health Systems-Charlottesville-United States-C Novartis' Investigator United States Virginia Charlottesville
University of Cincinnati 3-Cincinnati-United States-C Novartis' Investigator United States Ohio Cincinnati
Virginia Mason Medical Center 1-Seattle-United States-C Novartis' Investigator United States Washington Seattle
University of California Irvine Medical Centre 3-Orange-United States-C Novartis' Investigator United States California Orange
Meharry Medical College-Nashville-United States-C Novartis' Investigator United States Tennessee Nashville
Texas Oncology, PA-Bedford-Bedford-United States-C Novartis' Investigator United States Texas Bedford
UCSF Comprehensive Cancer Center-San Francisco-United States-C Novartis' Investigator United States California San Francisco
Washington University, Barnes-Jewish Hospital-St. Louis-United States-C Novartis' Investigator United States Missouri St. Louis
Utah Cancer Specialists-Salt Lake City-United States-C Novartis' Investigator United States Utah Salt Lake City
University of Iowa-Iowa City-United States-C Novartis' Investigator United States Iowa Iowa City
Beth Israel Deaconess Medical Cnt/Harvard Medical-Boston-United States-C Novartis' Investigator United States Massachusetts Boston
Hudson Valley Urology-Poughkeepsie-United States-C Novartis' Investigator United States New York Poughkeepsie
Hackensack University Medical Center-Hackensack-United States-C Novartis' Investigator United States New Jersey Hackensack
University Of Texas MD Anderson Cancer Center 3-Houston-United States-C Novartis' Investigator United States Texas Houston
Cedar Sinai Medical Center-West Hollywood-United States-C Novartis' Investigator United States California Los Angeles
The West Clinic-Memphis-United States-C Novartis' Investigator United States Tennessee Memphis
Kaiser Permanente Medical Center-Santa Clara-United States-C Novartis' Investigator United States California Santa Clara
Highline Medical Oncology-Burien-United States-C Novartis' Investigator United States Washington Burien
Tower Hematology Oncology Medical Group-Beverly Hills-United States-C Novartis' Investigator United States California Beverly Hills
Doctors Medical Center -JC Robinson Reg Cancer Ctr-San Pablo-United States-C Novartis' Investigator United States California San Pablo
Peachtree-Hematology Oncology Consultants-Atlanta-United States-C Novartis' Investigator United States Georgia Atlanta
Urology of Virginia-Virginia Beach-United States-C Novartis' Investigator United States Virginia Norfolk
Stanford University Clinical Cancer Center-Stanford-United States-C Novartis' Investigator United States California Stanford
UMass Memorial Medical Center-Worcester-United States-C Novartis' Investigator United States Massachusetts Worcester
Norris Comprehensive Cancer Center-Los Angeles-United States-C Novartis' Investigator United States California Los Angeles
Temple University-Philadelphia-United States-C Novartis' Investigator United States Pennsylvania Philadelphia
Indiana University Cancer Center-6-Indianapolis-United States-C Novartis' Investigator United States Indiana Indianapolis
Virginia Oncology Associates-Hampton-United States-C Novartis' Investigator United States Virginia Hampton
Lakeland Regional Cancer Center-Lakeland-United States-C Novartis' Investigator United States Florida Lakeland
Columbia Presbyterian Medical Center-New York-United States-C Novartis' Investigator United States New York New York
Kaiser Permanente Medical Center-Vallejo-United States-C Novartis' Investigator United States California Vallejo
Joe Arrington Cancer Center-Lubbock-United States-C Novartis' Investigator United States Texas Lubbock
Kaiser Permanente Walnut Creek-Walnut Creek-United States-C Novartis' Investigator United States California Walnut Creek
Massachusetts General Hospital Cancer Center-Boston-United States-C Novartis' Investigator United States Massachusetts Boston
The Vanderbilt Clinic-Nashville-United States-C Novartis' Investigator United States Tennessee Nashville
Georgetown University Medical Center-Washington-United States-C Novartis' Investigator United States District of Columbia Washington
Akron General Medical Center-Akron-United States-C Novartis' Investigator United States Ohio Akron
Brinz Burroff Gurtler Russo Mds-Metairie-United States-C Novartis' Investigator United States Louisiana Metairie
Jefferson Hospital-Philadelphia-United States-C Novartis' Investigator United States Pennsylvania Philadelphia
Pennsylvania Oncology Hematology Associates-Philadelphia-United States-C Novartis' Investigator United States Tennessee Memphis
Virginia Cancer Care-Richmond-United States-C Novartis' Investigator United States Virginia Richmond
Cleveland Clinic-Cleveland-United States-C Novartis' Investigator United States Ohio Cleveland
Hematology Oncology Medical Group of Fresno-Fresno-United States-C Novartis' Investigator United States California Fresno
Kaiser Permanente - Roseville-Roseville-United States-C Novartis' Investigator United States California Roseville
Medical Oncology Associates-Spokane-United States-C Novartis' Investigator United States Washington Spokane
St. Louis VA Medical Center-St. Louis-United States-C Novartis' Investigator United States Missouri St. Louis
Front Range Cancer Specialists-Fort Collins-United States-C Novartis' Investigator United States Colorado Fort Collins
New York Oncology Hematology-Albany-United States-C Novartis' Investigator United States New York Albany
Providence Medical Center-Portland-United States-C Novartis' Investigator United States Oregon Portland
Beth Israel Comprehensive Cancer Center-New York-United States-C Novartis' Investigator United States New York New York
Mercy Physicians of Oklahoma - Mercy Health Center-Oklahoma City-United States-C Novartis' Investigator United States Oklahoma Oklahoma City
Florida Cancer-Ft. Myers-United States-C Novartis' Investigator United States Virginia Ft. Myer
Feinberg School of Medicine Dept. of Urology-Chicago-United States-C Novartis' Investigator United States Illinois Chicago
Suniti Medical Corporation-Merrillville-United States-C Novartis' Investigator United States Indiana Merriville
Summit Cancer Ctr-2-Savannah-United States-C Novartis' Investigator United States Georgia Savannah
Texas Oncology-Houston-United States-C Novartis' Investigator United States Texas The Woodlands
Dana Farber Cancer Institute-Boston, MA-United States-C Novartis' Investigator United States Massachusetts Boston
Comprehensive Cancer Centers of Nevada-Eastern-Las Vegas-United States-C Novartis' Investigator United States Nevada Las Vegas
Florida Cancer Specialists-Fort Myers-United States-C Novartis' Investigator United States Florida Fort Myers
Tennessee Oncology-Nashville-United States-C Novartis' Investigator United States Tennessee Nashville
Oncology Hematology Care-Cincinnati-United States-C Novartis' Investigator United States Ohio Cincinnati
University of Cincinnati-Cincinnati-United States-C Novartis' Investigator United States Ohio Cincinnati
Duluth Clinic-Duluth-United States-C Novartis' Investigator United States Minnesota Duluth
Lahey Clinic-Burlington-United States-C Novartis' Investigator United States Massachusetts Burlington
Robert Wood Johnson Medical School-New Brunswick-United States-C Novartis' Investigator United States New Jersey New Brunswick
Nebraska Medical Center-Omaha-United States-C Novartis' Investigator United States Nebraska Omaha
David Geffen School of Medicine at UCLA-Los Angeles-United States-C Novartis' Investigator United States California Los Angeles
Kaiser Satellite South San Francisco-South San Francisco-United States-C Novartis' Investigator United States California South San Francisco
Clopton Clinic-Jonesboro-United States-C Novartis' Investigator United States Tennessee Memphis
Methodist Eastbrook Cancer Center-Omaha-United States-C Novartis' Investigator United States Nebraska Omaha
Park Nicollet Institute-St. Louis Park-United States-C Novartis' Investigator United States Minnesota St. Louis Park
University of Miami - Sylvester Cancer Center-Miami-United States-C Novartis' Investigator United States Florida Miami
Central Georgia Cancer Care, P.C.-Macon-United States-C Novartis' Investigator United States Tennessee Memphis
Clinical Trials Research Associated, Inc.-Montebello-United States-C Novartis' Investigator United States California Montebello
Kaiser Permanente Hayward-Hayward-United States-C Novartis' Investigator United States California Hayward
Kaiser Permanente Sacramento-Sacramento-United States-C Novartis' Investigator United States California Sacramento
St. Luke's - Roosevelt Hospital Center-New York-United States-C Novartis' Investigator United States New York New York
University of Michigan-Ann Arbor-United States-C Novartis' Investigator United States Michigan Ann Arbor
Johns Hopkins University-Baltimore-United States-C Novartis' Investigator United States Maryland Baltimore
北京301 医院 张旭 中国 北京 北京

伦理委员会信息

名称 审查结论 审查日期
复旦大学附属肿瘤医院(该研究的国内组长机构)医学伦理委员会 修改后同意 2011-11-28
复旦大学附属肿瘤医院医学伦理委员会 同意 2017-08-28

试验状态信息

试验状态
已完成
目标入组人数
国内: 40 ; 国际: 1500 ;
已入组例数
国内: 37 ; 国际: 1538 ;
实际入组总例数
国内: 37  ; 国际: 1538 ;
第一例受试者签署知情同意书日期
国内:2011-12-30;     国际:2010-11-30;
第一例受试者入组日期
国内:2012-01-13;     国际:2010-12-09;
试验终止日期
国内:2019-01-30;     国际:2019-04-15;

临床试验结果摘要

版本号 版本日期

发布
问题